“The whole emphasis on personalized medicine has been way over-hyped. Eventually we’ll get there, but in regard to the promise of pharmacogenetics, the clinicians don’t know what to do with it.”

“The availability of [Roche’s AmpliChip CYP450 Test] has brought the field of pharmacogenentics to the threshold of influencing clinical practice,” wrote the study’s authors.